LysForLivet IVS — Credit Rating and Financial Key Figures

LysForLivet IVS (CVR number: 38612018) is a company from FAXE. The company reported a net sales of 0.1 mDKK in 2020, demonstrating a growth of 108.7 % compared to the previous year. The operating profit percentage was poor at -9.2 % (EBIT: -0 mDKK), while net earnings were -21.9 kDKK. The profitability of the company measured by Return on Assets (ROA) was -23.3 %, which can be considered poor and Return on Equity (ROE) was -58.6 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 60.3 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. LysForLivet IVS's liquidity measured by quick ratio was 2.5 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.